Total eosinophil counts in the management of bronchial asthma.
about
Benralizumab: a unique IL-5 inhibitor for severe asthmaAsthma outcomes: biomarkersActivation of A3 adenosine receptors on human eosinophils elevates intracellular calciumImmunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population.Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma.Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.Childhood asthma--advances in pathogenesis.Comparison of whole-blood eosinophil counts in extrinsic asthmatics with acute and chronic asthma.Clinical value of monitoring eosinophil activity in asthma.Exercise-induced bronchocontriction, skin sensitivity, and serum IgE in children with eczemaBronchial asthma: is personalized therapy on the horizon?Use of mechanical ventilation in adults with severe asthma.Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSFPeripheral blood eosinophil counts and bronchial responsivenessDiurnal variation in serum cortisol concentrations in asthmatic subjects after allergen inhalationLeukotriene generation by eosinophils.Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblastsNew insights into airway inflammation by endobronchial biopsy.Evaluation of Antiasthmatic Activity of Curculigo orchioides Gaertn. Rhizomes.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.Which biomarkers are effective for identifying Th2-driven inflammation in asthma?Biomarkers of eosinophilic inflammation in asthma.Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial?Update on reslizumab for eosinophilic asthma.The current and future role of biomarkers in type 2 cytokine-mediated asthma management.Evaluation of the eosinophil.The inflammatory theory of asthma.Appraisals of cromolyn sodium and corticosteroids in the treatment of the asthmatic child.Cutting Edge: Eosinophils Undergo Caspase-1-Mediated Pyroptosis in Response to Necrotic Liver Cells.IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells.Clinical and symptom measures.Mechanism of airway inflammation in asthma.Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Inflammatory markers in childhood asthma.Anti-leukotriene agents: a new direction in asthma therapy.Intractable asthma care in children.Medical and ventilatory management of status asthmaticus.Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs
P2860
Q26750711-E21A8BA3-872A-40D3-8F72-1A4D70640402Q30425168-5F27DF00-C18F-410B-B36C-8489BFBBAAB4Q33802595-2B787831-3D57-472F-9604-0B40DD92AAEAQ33853714-0D9B9273-6BD6-4F62-983E-401D7E385B58Q33876003-86F6E749-758F-4AAB-86A8-144DFCFFD1FAQ33899436-D6E68493-4F12-4E77-98A8-BF3E0B364D3AQ33929161-199B32C1-BB1B-423A-8808-0821FE320092Q34764021-F7E509FF-862C-4A6C-AFBC-37C62BF0811FQ34797477-6857F8BB-FB7E-4AAC-85AE-D7B63CCD6C47Q34989472-4C89EBCF-2BCE-432B-A415-721BD0766999Q35777120-96E04111-E492-47F6-A28D-266AAA69107BQ35807712-F1906475-5C06-4B6F-ADA0-95907FF2B81CQ35873343-BA9543E1-1E12-4730-86F1-EDBE24DBBED0Q36167650-F1A38160-C162-4AF6-8ADF-25BE9C1742D2Q36203833-DE0CEF63-B165-46CE-930D-E6183A30E1B6Q36346186-17F1793F-9A8B-48A2-8FF7-E72177EFA65AQ36353710-2297331E-EA16-48A9-9686-CFFDF423B781Q36755532-FEABC4A4-E9AF-4EAA-9440-46372E2BDFEDQ37472746-17A33FA1-C062-47FE-9506-17C10C8F4E3DQ37522916-31F57660-3976-4AED-B3B1-3C3B4E9D2B75Q37690942-D4030ADA-5598-4E76-95B1-F9CA4EAE561FQ38126882-28E22359-E317-47CB-A817-D86B82CCB8EDQ38181529-1DAFC49B-EB93-4298-B8DD-E017D8AB3068Q38391330-D233B498-3AD7-42AF-A082-0252CC90B05FQ38587334-341AC7B4-2A8B-4B82-A71D-A9282925795AQ38764451-14FDC6F2-9FB9-4A89-8D24-71F7D8665E23Q38956508-9AC9EB7E-E22A-401A-B992-71C0012785A1Q39693850-1C1DBF44-46CD-41A7-B51C-765AB0A4E84EQ39864725-26330557-917A-466E-9C3F-E89C55ED7A05Q40157154-04160053-5336-47AA-B094-5CE659E9C897Q40775231-E848DA52-2B45-4CF1-93DA-9BEED6B6FA25Q40809825-B6941ABC-6069-4F52-B198-4FA7D5847F48Q40907944-37893C30-DF79-4034-9B4E-A64ABC4C68B8Q40920142-636267A0-8782-4828-A069-98FF1A30BADFQ41250324-82C2297A-6766-44E7-B987-373FE288482DQ41270730-CBB33C8A-727F-47EE-921E-7B0D27EC302EQ41316047-DEB4D714-64E1-46FB-BA03-94F411938BB5Q41737153-0BF8E398-8DD0-4E24-B5DA-8A38B921B7C1Q41952800-0CC2976B-0F9A-4D66-A6FE-D5F10D095FC6Q42009694-6D6FC84E-65C0-4797-997C-CB0A12673B1E
P2860
Total eosinophil counts in the management of bronchial asthma.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Total eosinophil counts in the management of bronchial asthma.
@en
Total eosinophil counts in the management of bronchial asthma.
@nl
type
label
Total eosinophil counts in the management of bronchial asthma.
@en
Total eosinophil counts in the management of bronchial asthma.
@nl
prefLabel
Total eosinophil counts in the management of bronchial asthma.
@en
Total eosinophil counts in the management of bronchial asthma.
@nl
P2093
P1476
Total eosinophil counts in the management of bronchial asthma.
@en
P2093
P304
P356
10.1056/NEJM197505292922204
P407
P577
1975-05-01T00:00:00Z